Kramer, Levin, Naftlais & Frankel LLP
Radiopharmaceutical formulations
Radiopharmaceutical compounds are disclosed having a radionuclide chelating moiety and a targeting ligand, and optionally a linker. Formulations of compositions useful for making the radiopharmaceutical compounds contain a chelating ligand, a reducing agent, an exchange ligand and a stabilizer.
Bracco Imaging S.p.A.
A A A
A61K A61K A61K
inventional inventional inventional
Aldo Nannan Jianqing Karen E.
Cagnolini Wang Chen Linder